PureCycle Technologies, Inc. (PCT)
NASDAQIndustrialsIndustrial - Pollution & Treatment ControlsSnapshot 2026-09-04
$6.39+1.11%
Close 2026-09-04 · 1-day change
NASDAQIndustrialsIndustrial - Pollution & Treatment ControlsSnapshot 2026-09-04
QuarterlyIQ Insights · PCT
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Continue scaling commercial resin deliveries, expanding customer base, and increasing revenue through regulatory-driven demand and new product approvals.
Stated as a priority in 3 of last 3 quarters. Revenue grew from $1.65 million in 2025-Q2 to $4.51 million in 2026-Q2, representing approximately 173% year-over-year growth and six consecutive quarters of sequential revenue increases. Management's statements and financial results show the company is delivering on commercial ramp and revenue growth.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Industrials names rated weak grew net income 53% of the time over the next year (vs 58% for the rest of the cohort, n=6963).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
“First P&G commercial resin deliveries began, with select Downy detergent caps now in commercial production.”
“Fifth consecutive quarter of sequential revenue growth, with continued progress in the application pipeline and branded conversions.”
“Reaffirming 40-50MM lbs. of demand beginning to ramp in Q2/Q3; 20-25MM lbs. of demand beginning to ramp in Q3/Q4.”
Manage capital expenditures with a revised guidance range reflecting increased project spend to support growth and new facility development.
Stated as a priority in 3 of last 3 quarters. Management raised fiscal year 2026 CAPEX guidance from $39-$45 million to $45-$50 million. Project spend totaled approximately $35 million in first half 2026, consistent with the updated guidance. The trajectory shows management is actively managing and increasing capital allocation to support growth.
“Fiscal year 2026 project spend expectations are $45 to $50 million, up from the prior range of $39 to $45 million.”
“Fiscal year 2026 project spend expectations of $39–45 million are unchanged and the majority remains discretionary.”
“Project spend expectations for 2026 remain $39 to $45 million.”
Complete concurrent public offerings of convertible senior notes and common stock to strengthen balance sheet and fund operations.
Stated as a priority in 2 of last 2 quarters. The company completed concurrent public offerings in June 2026, raising net proceeds of approximately $432 million. These proceeds were used to repurchase $216 million of existing convertible notes and to fund working capital, demonstrating delivery on the capital raise priority.
“Closed concurrent public offerings of $287.5 million convertible senior notes and 19.85 million shares of common stock.”
“Announced commencement of underwritten public offerings of $250 million convertible senior notes and $145 million common stock.”
Finish planned turnaround ahead of schedule and budget, improve reliability and production rates at the Ironton Facility.
Stated as a priority in 2 of last 2 quarters. The Ironton Facility turnaround was completed ahead of schedule and below budget, with over 170 projects executed. Production grew approximately 32% year over year despite the planned outage, indicating management is delivering on operational improvements.
“Turnaround completed ahead of schedule and below budget, with more than 170 reliability and rate projects executed.”
“Ironton Facility turnaround completed ahead of schedule and tracking below budget; incorporated improvement projects.”
Progress Thailand Facility construction plans, secure project financing, and target mechanical completion by end of 2027.
Stated as a priority in 2 of last 2 quarters. Management expects the Thailand Facility to be operational in 2028 with groundbreaking in second half 2026. Project financing is progressing with financial close targeted by year-end. The trajectory shows ongoing progress toward this strategic growth initiative.
“Thailand Facility expected to be operational in 2028; groundbreaking expected in 2H 2026; project financing progressing.”
“Thailand Facility currently on track for mechanical completion by end of 2027; expect to break ground in 2H 2026.”
Over the trailing year it converted 1.11x of net income into operating cash flow.
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, Fed net liquidity, long-term interest rates (low R² over the window).
31 material management or governance events in the past 24 months, led by capital-allocation actions. Historically, Industrials names rated volatile grew net income 58% of the time over the next year (vs 57% for the rest of the cohort, n=2592).
Not investment advice. As of 2026-09-04.